Medicine Man Technologies, Inc. (SHWZ) Stock Price & Analysis
Medicine Man Technologies, Inc. (SHWZ) — price $0.00001 (0.00%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Medicine Man Technologies, Inc. · SHWZ
Medicine Man Technologies, Inc., operating as Schwazze, is a cannabis company involved in retail, wholesale, and other cannabis-related activities. The company cultivates, manufactures, and sells cannabis products through its dispensaries and wholesale channels, primarily in Colorado and New Mexico.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.00001 | |
| Change on the day | 0.00% | |
| 52-week range | $0.000001 – $0.0022 | |
| Shares traded on the day | 3.2K |
Price & events
Other perspectives
Council score for Medicine Man Technologies (SHWZ): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 9, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Medicine Man Technologies (SHWZ), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Medicine Man Technologies, Inc. (SHWZ) is the company analyzed here. It employs 729 people and is led by Forrest Hoffmaster. In Q2 FY2024 it reported revenue of $43M and net income of -$14M.
What do the latest results show for Medicine Man Technologies (SHWZ)?
Short answer · as of
The most recent reported quarter, Q2 FY2024, carried revenue of $43M. Against analyst estimates the company has EPS beat 1 of the last 8 reports.
Quarterly income statement — 2 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2024 | $43M | -$14M | -$0.20 (diluted) |
| Q1 FY2024 | $42M | -$16M | -$0.24 (diluted) |
What are the financial strengths and risks for Medicine Man Technologies (SHWZ)?
Short answer · as of
The distress and quality screens read Altman Z -0.16 · Piotroski F 4. Trailing ratios: ROE -27.5% · ROA -9.6% · current ratio 0.97.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of -0.16 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-27.5%) — the business is not currently generating profit on shareholder capital.
- Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held SHWZ in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported SHWZ in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About SHWZ
These answers are editorial: 1 of these 1 answer is drawn from the SHWZ research dossier (written Mar 17, 2026 by gemini-2.0-flash). Figures in this section are not part of the source register.
What are the main risks for SHWZ?
The main risks for Medicine Man Technologies, Inc. include regulatory uncertainty, intense competition, and financial challenges. Changes in cannabis regulations at the state or federal level could significantly impact the company's operations and profitability. The cannabis industry is highly competitive, with numerous companies vying for market share. Schwazze faces competition from both established players and new entrants.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 7 from Financial Modeling Prep (FMP) and 6 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com